Isoquercitrin attenuates the osteoclast-mediated bone loss in rheumatoid arthritis via the Nrf2/ROS/NF-κB pathway
- 6 December 2023
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1870 (2) , 166977
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31971106)
This publication has 43 references indexed in Scilit:
- Osteoporosis: now and the futureThe Lancet, 2011
- Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen speciesExperimental & Molecular Medicine, 2011
- From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of OsteoporosisEndocrine Reviews, 2010
- Preventative Effect of a Flavonoid, Enzymatically Modified Isoquercitrin on Ocular Symptoms of Japanese Cedar PollinosisAllergology International, 2009
- Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in OsteoclastsCell, 2007
- A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiationBlood, 2005
- Evaluation of the toxicity of enzymatically decomposed rutin with 13-weeks dietary administration to Wistar ratsFood and Chemical Toxicology, 2004
- IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologyCytokine & Growth Factor Reviews, 2004
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- Bone and haematopoietic defects in mice lacking c-fosNature, 1992